Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Antibacterial agents

EMA committee recommends restrictions on use of quinolone and fluoroquinolone

A European Medicines Agency (EMA) committee has recommended that the use of fluoroquinolone and quinolone antibiotics should be restricted following a review of their disabling and potentially long-lasting side effects.

The Pharmacovigilance Risk Assessment Committee (PRAC) considered first-hand accounts of patients’ experiences of using the drugs, which were given at the EMA’s second ever public hearing on medicine usage in June 2018, before producing its recommendation on 5 October 2018.

The PRAC said that some medicines, including all those that contain a quinolone antibiotic, should be removed from the market. It also recommended that remaining fluoroquinolone antibiotics should not be used to treat minor infections and should be used with caution, particularly in older people, patients with kidney problems, patients who have had an organ transplant, and patients who are being treated with a systemic corticosteroid.

The EMA’s review of this class of antibiotics began in February 2017 at the request of the Federal Institute for Drugs and Medical Devices, the medical regulatory body in Germany, following reports of long-lasting side effects in its national database and published literature. Reported disabling side effects mainly involved muscles, tendons, bones and the nervous system.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205578

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.